Tagged Articles

bladder cancer 309 articles

Wrongful Death Lawsuit Filed Against DuPont alleging Carcinogen Exposure

A wrongful death lawsuit has been filed against E.I. DuPont De Nemours, a science and engineering company that makes construction materials, polymers, paints, plastics, printing materials, and more, alleging long-term exposure to “a potent bladder carcinogen known as aminobiphenyl” made a former employee sick. The estate of William Clawson filed the lawsuit in Jefferson County District Court in Texas on April 5, saying Clawson was a long-term employee of DuPont who was exposed to a chemical that led to his death. The suit alleges Clawson’s job description required him to work around aminobiphenyl, a “known human bladder carcinogen,” according to a hazard document produced by ... Read More

Cough medicine may help lower blood sugar in diabetic patients

An ingredient found in over-the-counter cough medicines may help lower blood sugar levels and could one day be used for the treatment of type 2 diabetes, according to new research published in the journal Nature Medicine. Researchers at Heinrich Heine University in Dusseldorf, Germany, have discovered that the drug dextromethorphan, when consumed, metabolizes into a compound called dextrorphan. This compound is what triggers the insulin release from the pancreas. The drug suppresses the activity of certain receptors called N-Methyl-D-Aspartate (NMDA) in the medulla oblongata, located in the brainstem just above the spinal cord. NMDA receptors also are found in the ... Read More

Study clears Nesina of heart risk; cancer risk still questionable

The type 2 diabetes drug Nesina (alogliptin) does not increase the risk of heart failure or cardiovascular risk, according to a new study published in the journal The Lancet. Death and disability from heart disease is rampant among individuals with type 2 diabetes. Concerns have been raised over the years about how some diabetes medications affect cardiovascular health after the drug Avandia was severely restricted when studies linked the medication to fatal heart attacks. As a result, Food and Drug Administration (FDA) now requires that a comprehensive evaluation of the cardiovascular safety profile be conducted on all new diabetic therapies. ... Read More

FDA approves first wireless diabetes glucose monitoring app

The Food and Drug Administration (FDA) has approved the first seamless diabetes glucose monitoring app, which can wirelessly transmit glucose readings directly to an iPhone, giving diabetics more flexibility when it comes to managing their disease. Federal drug and medical device regulators gave a nod to the new version of the Dexcom Share platform, which works with the Dexcom G4 continuous glucose monitor (CGM). The original Dexcom Share, which was approved by the FDA in October 2014, was a docking cradle peripheral that could transmit Dexcom’s glucose readings to a nearby iPhone. The readings were then uploaded through the cloud ... Read More

Another Actos bladder cancer case goes to trial

In 2011, three years after John Kristufek began taking the type 2 diabetes drug Actos,, he developed bladder cancer. Coincidentally that same year, studies linked Actos to an increased risk of type 2 diabetes. Since then, evidence began to surface that Actos maker Takeda Pharmaceuticals knew its blockbuster diabetes drug could cause bladder cancer but failed to warn doctors or patients. Now, after several procedures to have recurring tumors removed and, subsequently his entire bladder removed, Kristufek is getting his day in court. Kristufek’s filed his lawsuit alleging the Actos bladder cancer link in July 2012 in the Philadelphia Court ... Read More

Most diabetics stop taking glucose-lowering medications after cancer diagnosis

Most diabetics stop taking their glucose-lowering medications after they are diagnosed with cancer, according to a study published in the journal Diabetologia. The study, conducted by researchers with the Netherlands Comprehensive Cancer Organization in Eindhoven, involved new users of type 2 diabetes drugs between 1998 and 2011 from the Eindhoven Cancer Registry-PHARMO Database Network. From that database, researchers examined 3,281 patients diagnosed with cancer and 12,891 who were not diagnosed with cancer during follow-up. A medication possession ratio was used to determine drug adherence in both groups of patients. Researchers took note not only of cancer diagnosis, but also of ... Read More

Diabetes drug Januvia linked to heart failure hospitalizations

An observational study published in the journal JACC Heart Failure raises alarming questions about the type 2 diabetes drug Januvia (sitagliptin) and heart failure. The study involved an analysis of insurance claims from a database of more than 7,600 patients with diabetes and heart failure. Researchers found that people who took Januvia were just as likely as people who did not use Januvia to die or be hospitalized for any reason. However, patients using the drug were more likely to be hospitalized for heart failure. Researchers say the results could impact whether Januvia is prescribed as an add-on therapy for ... Read More

Many newer diabetes drugs carry cancer risks

Within the past two decades, thanks in large part to diabetes experts lowering the blood sugar threshold, millions more Americans were labeled as diabetic and became eligible for medication to help regulate blood sugar levels. As a result, the diabetes drug industry boomed. Sales of diabetes drugs topped $23 billion, more than the revenues generated from the National Football League, Major League Baseball, and the National Basketball Association combined. But in the past decade, a Milwaukee Journal Sentinel and MedPage Today investigation discovered that none of the 30 new diabetes drugs were proven to improve diabetics’ risk for associated health ... Read More

Dying man warns others of Actos bladder cancer risks

Before Tom Harbert died, he wanted to warn others not to let suspicious symptoms go unchecked. By the time he doctors found the source of his painful abdominal cramps, the cancerous tumor in his bladder had already made its way through the bladder wall. Doctors told him the prognosis was grim. About 70,000 people in the United States are diagnosed with bladder cancer each year and about 15,600 die from the disease annually. The No. 1 risk factor for bladder cancer is smoking. But Harbert, 51, was not a smoker nor was he around any chemicals that would have increased ... Read More

Insulin use linked to cardiovascular events, cancer, death

Type 2 diabetics taking insulin to control their blood sugar levels may be at greater risk of major cardiovascular events, cancer and death, and those taking higher doses of insulin are at even greater risk, according to new research published in the journal Diabetes, Obesity and Metabolism. Researchers with the Cardiff University School of Medicine in the United Kingdom said the findings add to ongoing concerns about insulin use to treat the chronic disease, adding that more research was needed on the issue. The study involved 6,484 patients with type 2 diabetes who were using insulin from the year 2000. ... Read More